Sanjiv Narayan, MD, is a PhD holder cardiologist and a professor of medicine at Stanford University. One of Dr. Sanjiv Narayan’s areas of expertise is atrial fibrillation, for which he advocates more effective therapies to handle the current rising trend of the condition in the United States.
Atrial fibrillation is a condition that causes an abnormal heart rate, typically one that is unusually fast and erratic. Pacemakers are a common solution, which means that the market for such devices correlates with the uptick in the diagnosis of the condition. The device can regulate the heart by sending it electrical signals that cause it to slow down and become more regular. The market for leadless pacing systems is growing due to the upwards trend of heart conditions in the US, which has been steadily increasing in individuals with lower incomes over the past few decades.
The growth of this market is also related to investment in more efficient ambulatory surgical centers, which allow patients to receive treatment without hospital admission. The rising rates of heart disease mean that more and more people will need such services daily, be it to have a new pacemaker fitted or full heart surgery.